A newly discovered type of stem cell could help brains repair themselves from injury or even debilitating diseases like Alzheimer’s, according to the latest research.
Called the “G2 quiescent stem cell”, it’s one of several ‘sleeping’ (or quiescent) stem cells in the brain.
But this one is showing more potential for regeneration than the others have so far. Like other stem cells, it can produce cells of all different types on demand – whatever the body needs.
It might sound crazy to the masses, but life extension is a real thing. The science, also known as anti-aging medicine, indefinite life extension, experimental gerontology, and biomedical gerontology, is the study of slowing down or reversing the processes that create aging. The result? Maximum and average lifespan extended. The question is, do we need tech? Or should we begin to look at why our life spans aren’t already longer?
If you try to envision it, you might find yourself lost in a futuristic sci-fi film you’ve already seen. But it’s more than a concept fit for the silver screen. Life extension is a very real science, and is currently being worked on as you read this.
According to some scientists, we are mere decades away from moving into life extension, which could change life as we know it forever.
The authors of a recent paper believe that in the future, artificial intelligence might be able to tell benign from malignant lesions without a biopsy.
Elon Musk’s Neuralink, the secretive company developing brain-machine interfaces, showed off some of the technology it has been developing to the public for the first time. The goal is to eventually begin implanting devices in paralyzed humans, allowing them to control phones or computers.
New research finds that neurons migrate from the brain to infiltrate cancer cells, and that targeting this process is a promising new method of attack on cancer.
In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory technique for creating an ovum with a donor nucleus. It can be used in embryonic stem cell research, or in regenerative medicine where it is sometimes referred to as “therapeutic cloning”.
https://www.biointeractive.org/classroom-resources/somatic-c…94yzh8K2uw
LOS ANGELES (AP) — New research gives some biological clues to why women may be more likely than men to develop Alzheimer’s disease and how this most common form of dementia varies by sex.
At the Alzheimer’s Association International Conference in Los Angeles on Tuesday, scientists offered evidence that the disease may spread differently in the brains of women than in men. Other researchers showed that several newly identified genes seem related to the disease risk by sex.
Two-thirds of Alzheimer’s cases in the U.S. are in women and “it’s not just because we live longer,” said Maria Carrillo, the association’s chief science officer. There’s also “a biological underpinning” for sex differences in the disease, she said.
A Sebastopol man is the first person to be diagnosed with a rare autoimmune condition that was triggered by an earlier bout of cancer. The disease was identified by a team led by UCSF researchers using new technology to screen for autoimmune disorders.
Safa and Marwa Ullah, who were born in Pakistan, were separated in a 50-hour series of operations at Great Ormond Street Hospital.
